Vanda Pharmaceuticals has prevailed in its case against the FDA. On Monday, a federal court sided in favor of Vanda in its Freedom of Information Act case against the agency regarding its sleep drug label expansion.
https://www.pharmalive.com/wp-content/uploads/2023/03/Polymeropoulos-Vanda.jpg350463BioSpacehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBioSpace2023-03-30 09:49:212023-03-30 09:49:21Court sides with Vanda against FDA in Freedom of Information Act case